Showing 501-520 of 753 for: Cochrane Systematic Reviews > Pharmacotherapeutics 
- Nutritional support for acute kidney injury
Cochrane Systematic Reviews, 19-Jul-2012
Treatment for acute kidney Injury (AKI) primarily relies on treating the underlying cause and maintaining the patient until kidney function has recovered. Enteral and parenteral nutrition are commonly used to treat nutritional disorders in AKI patients, h
- Olanzapine for schizophrenia
Cochrane Systematic Reviews, 12-Dec-2012
Olanzapine is an atypical antipsychotic reported to be effective without producing disabling extrapyramidal adverse effects associated with older, typical antipsychotic drugs.
- Omalizumab for asthma in adults and children
Cochrane Systematic Reviews, 18-Dec-2013
Asthma is a respiratory (airway) condition that affects an estimated 300 million people worldwide and is associated with significant morbidity and mortality. Omalizumab is a monoclonal antibody that binds and inhibits free serum immunoglobulin E (IgE). It
- Omega 3 fatty acid for the prevention of cognitive decline and dementia
Cochrane Systematic Reviews, 14-Aug-2012
Evidence from observational studies suggests that diets high in omega-3 long-chain polyunsaturated fatty acids (PUFA) may protect people from cognitive decline and dementia. The strength of this potential protective effect has recently been tested in rand
- Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease
Cochrane Systematic Reviews, 25-Jun-2014
The anti-inflammatory effects of n-3 (omega-3 fatty acids, fish oil) have been suggested to be beneficial in chronic inflammatory disorders such as inflammatory bowel disease. This review is an update of a previously published Cochrane review.
- Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis
Cochrane Systematic Reviews, 27-May-2008
Omega-3 fatty acids (n-3, fish oil) have been shown to have anti-inflammatory properties. Therefore, n-3 therapy may be beneficial in chronic inflammatory disorders such as ulcerative colitis.
- Omega 3 fatty acids for prevention and treatment of cardiovascular disease
Cochrane Systematic Reviews, 8-Sep-2008
It has been suggested that omega 3 (W3, n-3 or omega-3) fats from oily fish and plants are beneficial to health.
- Omega-3 fatty acids for bipolar disorder
Cochrane Systematic Reviews, 2-Nov-2008
Bipolar disorder is a complex psychiatric disorder and is amongst the top thirty causes of worldwide disability. Mood stabilisers are the primary pharmacological intervention, both in the treatment of acute episodes and in prophylaxis. There is, however,
- Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
Cochrane Systematic Reviews, 1-May-2015
In the initial treatment of venous thromboembolism (VTE) low molecular weight heparin (LMWH) is administered once or twice daily. A once daily treatment regimen is more convenient for the patient and may optimise home treatment. However, it is not clear w
- Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis
Cochrane Systematic Reviews, 4-Feb-2014
People with cystic fibrosis, who are chronically colonised with the organism Pseudomonas aeruginosa, often require multiple courses of intravenous aminoglycoside antibiotics for the management of pulmonary exacerbations. The properties of aminoglycosides
- One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates
Cochrane Systematic Reviews, 21-Sep-2011
Animal studies and trials in older children and adults suggest that a one dose per day regimen of gentamicin is superior to a multiple doses per day regimen.
- Opiate treatment for opiate withdrawal in newborn infants
Cochrane Systematic Reviews, 7-Sep-2010
Neonatal abstinence syndrome (NAS) due to opiate withdrawal may result in disruption of the mother-infant relationship, sleep-wake abnormalities, feeding difficulties, weight loss and seizures.
- Opioids compared to placebo or other treatments for chronic low-back pain
Cochrane Systematic Reviews, 21-Aug-2013
The use of opioids in the long-term management of chronic low-back pain (CLBP) has increased dramatically. Despite this trend, the benefits and risks of these medications remain unclear. This review is an update of a Cochrane review first published in 200
- Opioids for neuropathic pain
Cochrane Systematic Reviews, 17-Aug-2015
This is an updated version of the original Cochrane review published in Issue 3, 2006, which included 23 trials. The use of opioids for neuropathic pain remains controversial. Studies have been small, have yielded equivocal results, and have not establish
- Oral antibiotics versus parenteral antibiotics for severe pneumonia in children
Cochrane Systematic Reviews, 7-May-2009
Acute respiratory infection (ARI) is one of the leading causes of morbidity and mortality in children under five years of age in developing countries. When hospitalisation is required, the usual practice includes administering parenteral antibiotics if a
- Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks
Cochrane Systematic Reviews, 6-Mar-2011
Non-valvular atrial fibrillation (AF) carries an increased risk of stroke mediated by embolism of stasis-precipitated thrombi originating in the left atrial appendage. Both oral anticoagulants and antiplatelet agents have proven effective for stroke preve
- Oral antiplatelet therapy for acute ischaemic stroke
Cochrane Systematic Reviews, 14-Jan-2022
In people with acute ischaemic stroke, platelets become activated and can cause blood clots to form and block an artery in the brain, resulting in damage to part of the brain. Such damage gives rise to the symptoms of stroke. Antiplatelet therapy might re
- Oral anti-pseudomonal antibiotics for cystic fibrosis
Cochrane Systematic Reviews, 29-Oct-2013
Pseudomonas aeruginosa is the most common bacterial pathogen causing lung infections in people with CF and appropriate antibiotic therapy is vital. Antibiotics for pulmonary exacerbations are usually given intravenously, and for long-term treatment, via
- Oral beta-blockers for mild to moderate hypertension during pregnancy
Cochrane Systematic Reviews, 5-Jul-2012
Antihypertensives, such as beta-blockers, are used for pregnancy hypertension in the belief these will improve outcome for mother and baby.
- Oral corticosteroids for bronchiectasis (stable and acute exacerbations)
Cochrane Systematic Reviews, 10-May-2011
Inflammation plays a significant role in the pathophysiology of bronchiectasis. Two small studies have shown small benefits from inhaled corticosteroids and oral corticosteroids may be of benefit in bronchiectasis
